A multivariable sensitivity analysis conducted on a pharmacy follow-up program of high-risk patients demonstrated cost savings to hospitals in 98.3% of head-to-head trials across 1000 hypothetical hospitals.
Duong Donna Luong, PharmD
Advertisement
Articles by Duong Donna Luong, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
3
Who Recommends COVID-19 Vaccines Without ACIP?
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5